Successful reduced-intensity stem cell transplant from one-locus HLA-mismatched unrelated cord blood after rejection of unrelated bone marrow in an infant with myelogenous leukemia

Hematology

Volumn 7, Issue 2, 2002, Pages 101-103

  Shibuya, Atsushi ^a   Kaneko, Ieaki ^a   Ishii, Saori ^a   Sasaki, Nozomu ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cord blood stem cell transplantation; Graft versus leukemia; HLA A locus; Infant leukemia

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; CYTARABINE; FLUDARABINE; HLA A ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DR ANTIGEN; METHOTREXATE; TACROLIMUS;

ARTICLE; CANCER RECURRENCE; CANCER REGRESSION; CASE REPORT; DONOR; FEMALE; GASTROINTESTINAL DISEASE; GENOTYPE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HISTOCOMPATIBILITY; HUMAN; INFANT; LIVER DISEASE; MYELOID LEUKEMIA; PHENOTYPE; PRIORITY JOURNAL; SKIN DISEASE; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; UMBILICAL CORD BLOOD; ACUTE GRANULOCYTIC LEUKEMIA; ALLOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; CORD BLOOD STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; METHODOLOGY; RECURRENT DISEASE;

BONE MARROW TRANSPLANTATION; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; GRAFT REJECTION; GRAFT VS HOST DISEASE; GRAFT VS LEUKEMIA EFFECT; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HUMANS; INFANT; LEUKEMIA, MYELOCYTIC, ACUTE; RECURRENCE; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 0036292804     PISSN: 10245340     EISSN: None     Source Type: Journal    
DOI: 10.1080/10245330290022142     Document Type: Article

References (8)

1. "Identification of two risk groups in acute myelogenous leukemia after intensification in study AML-BEM-83 as with study AML-BFM-78"
2. "Biology and treatment of infant leukemias"
3. "Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and non-malignant hematologic disease"
4. "Engraftment of allogeneic hematopoietic cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy"
5. "Outcome of cord-blood transplantation from related and unrelated donors"
6. "Transplant-lite: Induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies"
7. "In vitro and in vivo assessment of the graft-versus-leukemia activity of cord blood"
8. "Generated of HLA-A2 subtype specific cytotoxic T lymphocytes from cord blood used for cord blood stem cell transplantation"